Morgan Stanley Innoviva, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Innoviva, Inc. stock. As of the latest transaction made, Morgan Stanley holds 1,002,365 shares of INVA stock, worth $19.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,002,365

Previous 932,950 7.44%

Holding current value

$19.2 Million

Previous $15.3 Million 26.44%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$16.33 - $20.04 $1.13 Million - $1.39 Million	69,415 Added 7.44%	1,002,365 $19.3 Million
Q2 2024 Oct 17, 2024	SELL	$14.4 - $16.4 $3.56 Million - $4.06 Million	-247,453 Reduced 20.96%	932,950 $15.3 Million
Q2 2024 Aug 14, 2024	SELL	$14.4 - $16.4 $3.56 Million - $4.06 Million	-247,453 Reduced 20.96%	932,950 $15.3 Million
Q1 2024 Oct 17, 2024	BUY	$14.56 - $16.78 $3.6 Million - $4.15 Million	247,453 Added 26.52%	1,180,403 $18 Million
Q1 2024 Aug 16, 2024	SELL	$14.56 - $16.78 $13.6 Million - $15.7 Million	-936,754 Reduced 44.25%	1,180,403 $18 Million
Q1 2024 May 15, 2024	SELL	$14.56 - $16.78 $13.6 Million - $15.7 Million	-936,754 Reduced 44.25%	1,180,403 $18 Million
Q4 2023 Aug 16, 2024	BUY	$12.32 - $16.27 $14.6 Million - $19.3 Million	1,184,207 Added 126.93%	2,117,157 $34 Million
Q4 2023 Feb 13, 2024	BUY	$12.32 - $16.27 $15.8 Million - $20.8 Million	1,278,776 Added 152.53%	2,117,157 $34 Million
Q3 2023 Nov 15, 2023	BUY	$12.37 - $13.89 $1.04 Million - $1.16 Million	83,750 Added 11.1%	838,381 $10.9 Million
Q2 2023 Aug 14, 2023	SELL	$11.39 - $13.72 $3.23 Million - $3.89 Million	-283,722 Reduced 27.32%	754,631 $9.61 Million
Q1 2023 May 15, 2023	SELL	$10.73 - $13.6 $3.49 Million - $4.42 Million	-325,243 Reduced 23.85%	1,038,353 $11.7 Million
Q4 2022 Feb 14, 2023	SELL	$11.8 - $13.78 $6.94 Million - $8.1 Million	-588,170 Reduced 30.14%	1,363,596 $18.1 Million
Q3 2022 Nov 14, 2022	BUY	$11.61 - $15.22 $2.11 Million - $2.77 Million	181,903 Added 10.28%	1,951,766 $22.7 Million
Q2 2022 Oct 27, 2022	BUY	$14.32 - $19.88 $3.5 Million - $4.87 Million	244,756 Added 16.05%	1,769,863 $26.1 Million
Q2 2022 Aug 15, 2022	BUY	$14.32 - $19.88 $3.5 Million - $4.87 Million	244,756 Added 16.05%	1,769,863 $26.1 Million
Q1 2022 Oct 27, 2022	SELL	$15.39 - $20.25 $3.77 Million - $4.96 Million	-244,756 Reduced 13.83%	1,525,107 $29.5 Million
Q1 2022 May 13, 2022	BUY	$15.39 - $20.25 $16.5 Million - $21.7 Million	1,072,828 Added 237.2%	1,525,107 $29.5 Million
Q4 2021 Feb 14, 2022	SELL	$15.91 - $18.72 $7.11 Million - $8.36 Million	-446,684 Reduced 49.69%	452,279 $7.8 Million
Q3 2021 Nov 15, 2021	BUY	$13.06 - $17.24 $11.7 Million - $15.5 Million	898,963 New	898,963 $15 Million

Others Institutions Holding INVA

# of Institutions

229

Shares Held

79.2M

Call Options Held

37.6K

Put Options Held

300

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account